OPUS GENETICS Trademark

Trademark Overview

On Monday, February 21, 2022, a trademark application was filed for OPUS GENETICS with the United States Patent and Trademark Office. The USPTO has given the OPUS GENETICS trademark a serial number of 97276810. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, August 12, 2024. This trademark is owned by Opus Genetics, Inc.. The OPUS GENETICS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical and biologic preparations for the diagnosis and treatment of retinal and ocular diseases; pharmaceutical and biologic preparations for human use for the treatment of retinal and ocular diseases through gene therapy
opus genetics

General Information

Serial Number97276810
Word MarkOPUS GENETICS
Filing DateMonday, February 21, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, August 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 17, 2023

Trademark Statements

Description of MarkThe mark consists of the stylized word OPUS above the stylized word GENETICS with a stylized swirl with a slash going through the center of the swirl to the left of OPUS GENETICS.
Goods and Servicespharmaceutical and biologic preparations for the diagnosis and treatment of retinal and ocular diseases; pharmaceutical and biologic preparations for human use for the treatment of retinal and ocular diseases through gene therapy
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"GENETICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 24, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOpus Genetics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRaleigh, NC 27603
Party NameOpus Genetics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRaleigh, NC 27603

Trademark Events

Event DateEvent Description
Friday, February 25, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, February 24, 2022NEW APPLICATION ENTERED
Thursday, February 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 5, 2022ASSIGNED TO EXAMINER
Monday, December 5, 2022NON-FINAL ACTION WRITTEN
Monday, December 5, 2022NON-FINAL ACTION E-MAILED
Monday, December 5, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 7, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 7, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 8, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 17, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 20, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 20, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 20, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 20, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, September 7, 2023SOU TEAS EXTENSION RECEIVED
Thursday, September 7, 2023SOU EXTENSION 1 FILED
Thursday, September 7, 2023SOU EXTENSION 1 GRANTED
Saturday, September 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 28, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, February 28, 2024SOU EXTENSION 2 FILED
Monday, August 12, 2024SOU TEAS EXTENSION RECEIVED
Monday, August 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 12, 2024SOU EXTENSION 3 FILED
Monday, August 12, 2024SOU EXTENSION 3 GRANTED
Thursday, February 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 28, 2024SOU EXTENSION 2 GRANTED

Related Keywords

genetics opus pharmaceutical ocular diseases treatment retinal biologic preparations therapy gene human